| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 5.88e-05 | 7 | 34 | 2 | GO:0004028 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.04e-04 | 145 | 34 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.83e-04 | 65 | 34 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 2.53e-04 | 14 | 34 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 2.91e-04 | 15 | 34 | 2 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 3.77e-04 | 17 | 34 | 2 | GO:0004030 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.05e-04 | 85 | 34 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.02e-03 | 48 | 34 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 3.95e-03 | 55 | 34 | 2 | GO:0051879 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.09e-03 | 56 | 34 | 2 | GO:0016903 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 1.15e-04 | 10 | 34 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.68e-04 | 12 | 34 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | apical part of cell | 3.44e-04 | 592 | 34 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.07e-03 | 487 | 34 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network | 1.16e-03 | 31 | 34 | 2 | GO:0071782 | |
| MousePheno | enlarged frontal bone | 8.67e-05 | 7 | 29 | 2 | MP:0004375 | |
| MousePheno | enlarged interparietal bone | 8.67e-05 | 7 | 29 | 2 | MP:0004386 | |
| MousePheno | thick myocardium | 8.67e-05 | 7 | 29 | 2 | MP:0010656 | |
| MousePheno | abnormal cochlear outer hair cell number | 1.47e-04 | 50 | 29 | 3 | MP:0004400 | |
| Domain | TyrKc | 1.92e-05 | 88 | 34 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.92e-05 | 88 | 34 | 4 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 2.81e-05 | 97 | 34 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.81e-05 | 97 | 34 | 4 | IPR008266 | |
| Domain | Pkinase_Tyr | 8.58e-05 | 129 | 34 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.11e-04 | 138 | 34 | 4 | IPR001245 | |
| Domain | Ig_I-set | 3.79e-04 | 190 | 34 | 4 | IPR013098 | |
| Domain | I-set | 3.79e-04 | 190 | 34 | 4 | PF07679 | |
| Domain | Ald_DH_CS_GLU | 3.80e-04 | 16 | 34 | 2 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 4.30e-04 | 17 | 34 | 2 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.83e-04 | 18 | 34 | 2 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.83e-04 | 18 | 34 | 2 | PS00070 | |
| Domain | - | 5.39e-04 | 19 | 34 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 5.39e-04 | 19 | 34 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 5.39e-04 | 19 | 34 | 2 | IPR015590 | |
| Domain | - | 5.39e-04 | 19 | 34 | 2 | 3.40.309.10 | |
| Domain | Ald_DH_C | 5.39e-04 | 19 | 34 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 5.39e-04 | 19 | 34 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 5.39e-04 | 19 | 34 | 2 | IPR016161 | |
| Domain | IGc2 | 8.42e-04 | 235 | 34 | 4 | SM00408 | |
| Domain | Ig_sub2 | 8.42e-04 | 235 | 34 | 4 | IPR003598 | |
| Domain | - | 1.13e-03 | 663 | 34 | 6 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.55e-03 | 706 | 34 | 6 | IPR013783 | |
| Domain | FERM_M | 3.17e-03 | 46 | 34 | 2 | PF00373 | |
| Domain | FERM_central | 3.59e-03 | 49 | 34 | 2 | IPR019748 | |
| Domain | CUB | 3.59e-03 | 49 | 34 | 2 | PF00431 | |
| Domain | FERM_domain | 3.59e-03 | 49 | 34 | 2 | IPR000299 | |
| Domain | FERM_1 | 3.73e-03 | 50 | 34 | 2 | PS00660 | |
| Domain | FERM_2 | 3.73e-03 | 50 | 34 | 2 | PS00661 | |
| Domain | Band_41_domain | 3.73e-03 | 50 | 34 | 2 | IPR019749 | |
| Domain | CUB | 3.73e-03 | 50 | 34 | 2 | SM00042 | |
| Domain | B41 | 3.73e-03 | 50 | 34 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.73e-03 | 50 | 34 | 2 | IPR014352 | |
| Domain | FERM_3 | 3.73e-03 | 50 | 34 | 2 | PS50057 | |
| Domain | - | 4.03e-03 | 52 | 34 | 2 | 2.60.120.290 | |
| Domain | CUB | 4.18e-03 | 53 | 34 | 2 | PS01180 | |
| Domain | CUB_dom | 4.82e-03 | 57 | 34 | 2 | IPR000859 | |
| Domain | IG | 6.92e-03 | 421 | 34 | 4 | SM00409 | |
| Domain | Ig_sub | 6.92e-03 | 421 | 34 | 4 | IPR003599 | |
| Domain | - | 8.64e-03 | 449 | 34 | 4 | 3.30.40.10 | |
| Domain | MFS | 8.64e-03 | 77 | 34 | 2 | IPR011701 | |
| Domain | MFS_1 | 8.64e-03 | 77 | 34 | 2 | PF07690 | |
| Domain | Znf_RING/FYVE/PHD | 9.32e-03 | 459 | 34 | 4 | IPR013083 | |
| Domain | Prot_kinase_dom | 1.16e-02 | 489 | 34 | 4 | IPR000719 | |
| Domain | IG_LIKE | 1.17e-02 | 491 | 34 | 4 | PS50835 | |
| Domain | PROTEIN_KINASE_DOM | 1.19e-02 | 493 | 34 | 4 | PS50011 | |
| Domain | Ig-like_dom | 1.27e-02 | 503 | 34 | 4 | IPR007110 | |
| Pubmed | 4.21e-07 | 15 | 35 | 3 | 19464179 | ||
| Pubmed | Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects. | 9.84e-07 | 2 | 35 | 2 | 24616287 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15245423 | ||
| Pubmed | Retinoids control anterior and dorsal properties in the developing forebrain. | 9.84e-07 | 2 | 35 | 2 | 17184764 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20833146 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 7891157 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12819783 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 11025231 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19478994 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 25377086 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12454286 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24884875 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 31923393 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 35315776 | ||
| Pubmed | The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2. | 2.95e-06 | 3 | 35 | 2 | 30413670 | |
| Pubmed | Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer. | 2.95e-06 | 3 | 35 | 2 | 27015121 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 11744377 | ||
| Pubmed | EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. | 2.95e-06 | 3 | 35 | 2 | 19118217 | |
| Pubmed | Identification of active retinaldehyde dehydrogenase isoforms in the postnatal human eye. | 2.95e-06 | 3 | 35 | 2 | 25793304 | |
| Pubmed | Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. | 2.95e-06 | 3 | 35 | 2 | 21436255 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 18498088 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 18399539 | ||
| Pubmed | Astrocytes as a regulated source of retinoic acid for the brain. | 5.90e-06 | 4 | 35 | 2 | 22930583 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 21224842 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23484127 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 30487180 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23012458 | ||
| Pubmed | Non-cell-autonomous retinoid signaling is crucial for renal development. | 5.90e-06 | 4 | 35 | 2 | 20040494 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 11959834 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 34623260 | ||
| Pubmed | Spatiotemporal expression of IgLON family members in the developing mouse nervous system. | 9.82e-06 | 5 | 35 | 2 | 34599206 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 12808103 | ||
| Pubmed | Retinoic acid regulates olfactory progenitor cell fate and differentiation. | 1.47e-05 | 6 | 35 | 2 | 23829703 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 16615129 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 27506116 | ||
| Pubmed | A retinoic acid synthesizing enzyme in ventral retina and telencephalon of the embryonic mouse. | 1.47e-05 | 6 | 35 | 2 | 10906479 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 24699546 | ||
| Pubmed | Positive association between ALDH1A2 and schizophrenia in the Chinese population. | 2.06e-05 | 7 | 35 | 2 | 19703508 | |
| Pubmed | Retinoic acid signaling is dispensable for somatic development and function in the mammalian ovary. | 2.06e-05 | 7 | 35 | 2 | 28274610 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 32152201 | ||
| Pubmed | Retinaldehyde dehydrogenase enzymes regulate colon enteric nervous system structure and function. | 2.06e-05 | 7 | 35 | 2 | 23806210 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 19549509 | ||
| Pubmed | FGFR2 signaling enhances the SHH-BMP4 signaling axis in early ureter development. | 2.36e-05 | 55 | 35 | 3 | 35020897 | |
| Pubmed | Antagonism between retinoic acid and fibroblast growth factor signaling during limb development. | 2.74e-05 | 8 | 35 | 2 | 23623500 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 15161092 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 25261715 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 17207476 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 32665247 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 16611695 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 20737513 | ||
| Pubmed | ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. | 5.38e-05 | 11 | 35 | 2 | 23142317 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 29093497 | ||
| Pubmed | A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. | 5.38e-05 | 11 | 35 | 2 | 8247543 | |
| Pubmed | Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice. | 5.38e-05 | 11 | 35 | 2 | 16026781 | |
| Pubmed | A high-resolution molecular atlas of the fetal mouse lower urogenital tract. | 6.00e-05 | 75 | 35 | 3 | 21905163 | |
| Pubmed | A cell fitness selection model for neuronal survival during development. | 6.45e-05 | 12 | 35 | 2 | 31515492 | |
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 19854269 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 21705333 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 30166332 | ||
| Pubmed | Retinoic acid deficiency alters second heart field formation. | 6.45e-05 | 12 | 35 | 2 | 18287057 | |
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 26427057 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 32494737 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.75e-05 | 430 | 35 | 5 | 35044719 | |
| Pubmed | 6.90e-05 | 432 | 35 | 5 | 7671812 | ||
| Pubmed | Multifaceted Hoxa13 function in urogenital development underlies the Hand-Foot-Genital Syndrome. | 7.62e-05 | 13 | 35 | 2 | 30649340 | |
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 29986869 | ||
| Pubmed | 8.12e-05 | 83 | 35 | 3 | 11114734 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 18561907 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 18393306 | ||
| Pubmed | Retinoic acid functions as a key GABAergic differentiation signal in the basal ganglia. | 8.89e-05 | 14 | 35 | 2 | 21532733 | |
| Pubmed | Effect of retinoic acid signaling on Wnt/beta-catenin and FGF signaling during body axis extension. | 8.89e-05 | 14 | 35 | 2 | 19539783 | |
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 19519663 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 24361260 | ||
| Pubmed | The orphan GPCR, Gpr161, regulates the retinoic acid and canonical Wnt pathways during neurulation. | 1.02e-04 | 15 | 35 | 2 | 25753732 | |
| Pubmed | Retinoic acid controls early neurogenesis in the developing mouse cerebral cortex. | 1.02e-04 | 15 | 35 | 2 | 28790015 | |
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 19448158 | ||
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 23548203 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 25577283 | ||
| Pubmed | Retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. | 1.17e-04 | 16 | 35 | 2 | 16207763 | |
| Pubmed | Genome-wide association of body fat distribution in African ancestry populations suggests new loci. | 1.17e-04 | 16 | 35 | 2 | 23966867 | |
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 21930923 | ||
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 20503368 | ||
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 26446231 | ||
| Pubmed | Local retinoic acid signaling directs emergence of the extraocular muscle functional unit. | 1.85e-04 | 20 | 35 | 2 | 33201874 | |
| Pubmed | 1.85e-04 | 20 | 35 | 2 | 24005908 | ||
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 28715412 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 18971422 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 19737349 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 15766748 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.49e-04 | 569 | 35 | 5 | 30639242 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 2.91e-04 | 25 | 35 | 2 | 15254900 | |
| Pubmed | Identification of genes controlled by LMX1B in E13.5 mouse limbs. | 3.15e-04 | 26 | 35 | 2 | 20589901 | |
| Pubmed | 3.15e-04 | 26 | 35 | 2 | 18331719 | ||
| Pubmed | 3.40e-04 | 27 | 35 | 2 | 19168680 | ||
| Pubmed | Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. | 3.40e-04 | 27 | 35 | 2 | 23144326 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 3.42e-04 | 333 | 35 | 4 | 32665550 | |
| Pubmed | Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. | 3.93e-04 | 29 | 35 | 2 | 25624266 | |
| Pubmed | 3.93e-04 | 29 | 35 | 2 | 23077214 | ||
| Pubmed | 4.20e-04 | 30 | 35 | 2 | 16368932 | ||
| Pubmed | A genome-wide association study of behavioral disinhibition. | 4.20e-04 | 30 | 35 | 2 | 23942779 | |
| Cytoband | 11q25 | 1.81e-04 | 26 | 35 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 2.59e-04 | 31 | 35 | 2 | chr11q25 | |
| Cytoband | 15q26.3 | 4.54e-04 | 41 | 35 | 2 | 15q26.3 | |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 1.98e-05 | 5 | 26 | 2 | 1052 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.77e-05 | 161 | 26 | 4 | 593 | |
| GeneFamily | Aldehyde dehydrogenases | 3.35e-04 | 19 | 26 | 2 | 398 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.50e-03 | 40 | 26 | 2 | 321 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.17e-03 | 181 | 26 | 3 | 694 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.33e-03 | 50 | 26 | 2 | 1293 | |
| GeneFamily | Solute carriers | 1.85e-02 | 395 | 26 | 3 | 752 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-02 | 160 | 26 | 2 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 3.11e-02 | 193 | 26 | 2 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.51e-02 | 206 | 26 | 2 | 682 | |
| Coexpression | MEK_UP.V1_UP | 5.86e-06 | 195 | 35 | 5 | M2725 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 184 | 35 | 5 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 184 | 35 | 5 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-07 | 196 | 35 | 5 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.46e-07 | 197 | 35 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.16e-07 | 92 | 35 | 4 | 926e02725a03d8473eda25d4aef63e34a6566224 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.16e-07 | 92 | 35 | 4 | d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.53e-06 | 155 | 35 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.97e-06 | 168 | 35 | 4 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 175 | 35 | 4 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 175 | 35 | 4 | 030f93af5a96848b9118e2a8116e19ddae438d92 | |
| ToppCell | ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, Lineage and Cell Type | 1.05e-05 | 175 | 35 | 4 | c44fd1cc827296de7300d4a60399bb945089a170 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 175 | 35 | 4 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 177 | 35 | 4 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 177 | 35 | 4 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 179 | 35 | 4 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 186 | 35 | 4 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 187 | 35 | 4 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 187 | 35 | 4 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-05 | 190 | 35 | 4 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 191 | 35 | 4 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 191 | 35 | 4 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 193 | 35 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-05 | 194 | 35 | 4 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 194 | 35 | 4 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 196 | 35 | 4 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 196 | 35 | 4 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 197 | 35 | 4 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 198 | 35 | 4 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 198 | 35 | 4 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 198 | 35 | 4 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 198 | 35 | 4 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 35 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 199 | 35 | 4 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 199 | 35 | 4 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 35 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 35 | 4 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 35 | 4 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 35 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 35 | 4 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-05 | 200 | 35 | 4 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, condition lineage and cell class | 1.78e-05 | 200 | 35 | 4 | 09d5c3a3d2b42b15c769dc2bc14b6c0d5cc38f91 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.10e-05 | 107 | 35 | 3 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.10e-05 | 107 | 35 | 3 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 116 | 35 | 3 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 126 | 35 | 3 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 126 | 35 | 3 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 126 | 35 | 3 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 126 | 35 | 3 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 126 | 35 | 3 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-04 | 131 | 35 | 3 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.54e-04 | 133 | 35 | 3 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.91e-04 | 143 | 35 | 3 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 146 | 35 | 3 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 147 | 35 | 3 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 147 | 35 | 3 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 149 | 35 | 3 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 149 | 35 | 3 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.33e-04 | 153 | 35 | 3 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-04 | 153 | 35 | 3 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 2.47e-04 | 156 | 35 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-04 | 158 | 35 | 3 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-04 | 158 | 35 | 3 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 158 | 35 | 3 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-04 | 158 | 35 | 3 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 159 | 35 | 3 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 159 | 35 | 3 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 159 | 35 | 3 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-04 | 159 | 35 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.61e-04 | 159 | 35 | 3 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 159 | 35 | 3 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-04 | 162 | 35 | 3 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.76e-04 | 162 | 35 | 3 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-04 | 163 | 35 | 3 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 163 | 35 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 163 | 35 | 3 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-04 | 164 | 35 | 3 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 2.96e-04 | 166 | 35 | 3 | 9788486582cc2c5f28b9ea015e235732f9fefb1e | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 167 | 35 | 3 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 167 | 35 | 3 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 168 | 35 | 3 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.07e-04 | 168 | 35 | 3 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.07e-04 | 168 | 35 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 3.12e-04 | 169 | 35 | 3 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-04 | 170 | 35 | 3 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 170 | 35 | 3 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-04 | 174 | 35 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 175 | 35 | 3 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| Computational | Oxidoreductases. | 2.95e-04 | 14 | 20 | 2 | MODULE_464 | |
| Computational | Genes in the cancer module 194. | 3.40e-04 | 15 | 20 | 2 | MODULE_194 | |
| Drug | bis-diamine | 5.44e-07 | 11 | 35 | 3 | CID000015134 | |
| Disease | phosphatidylcholine measurement | 8.09e-07 | 284 | 34 | 6 | EFO_0010226 | |
| Disease | Schizophrenia | 5.67e-06 | 883 | 34 | 8 | C0036341 | |
| Disease | triacylglycerol 54:3 measurement | 6.15e-06 | 31 | 34 | 3 | EFO_0010421 | |
| Disease | 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0800471 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0800444 | |
| Disease | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0020014 | |
| Disease | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 2.70e-05 | 7 | 34 | 2 | EFO_0800470 | |
| Disease | 1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement | 2.70e-05 | 7 | 34 | 2 | EFO_0800443 | |
| Disease | level of Phosphatidylcholine (17:0_18:2) in blood serum | 2.70e-05 | 7 | 34 | 2 | OBA_2045086 | |
| Disease | level of Phosphatidylcholine (16:0_22:6) in blood serum | 2.70e-05 | 7 | 34 | 2 | OBA_2045080 | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 3.59e-05 | 8 | 34 | 2 | EFO_0800260 | |
| Disease | 1-linoleoyl-GPE (18:2) measurement | 3.59e-05 | 8 | 34 | 2 | EFO_0800247 | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 4.62e-05 | 9 | 34 | 2 | EFO_0800248 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 4.62e-05 | 9 | 34 | 2 | EFO_0800409 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement | 4.62e-05 | 9 | 34 | 2 | EFO_0800403 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement | 4.62e-05 | 9 | 34 | 2 | EFO_0800272 | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0800402 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0800608 | |
| Disease | cholesteryl ester 22:5 measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0021444 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 7.04e-05 | 11 | 34 | 2 | EFO_0800269 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 7.04e-05 | 11 | 34 | 2 | OBA_2045123 | |
| Disease | triacylglycerol 53:2 measurement | 8.44e-05 | 12 | 34 | 2 | EFO_0021484 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 8.44e-05 | 12 | 34 | 2 | EFO_0800466 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 8.44e-05 | 12 | 34 | 2 | OBA_2045157 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 8.44e-05 | 12 | 34 | 2 | OBA_2045074 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 9.97e-05 | 13 | 34 | 2 | OBA_2045174 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 9.97e-05 | 13 | 34 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 9.97e-05 | 13 | 34 | 2 | OBA_2045082 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.16e-04 | 14 | 34 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.16e-04 | 14 | 34 | 2 | OBA_2045142 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 1.16e-04 | 14 | 34 | 2 | OBA_2045143 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.34e-04 | 15 | 34 | 2 | OBA_2045131 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 1.34e-04 | 15 | 34 | 2 | OBA_2045165 | |
| Disease | phosphatidate measurement | 1.34e-04 | 15 | 34 | 2 | EFO_0020047 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.34e-04 | 15 | 34 | 2 | OBA_2045067 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 1.34e-04 | 15 | 34 | 2 | EFO_0800508 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.53e-04 | 16 | 34 | 2 | OBA_2045090 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.95e-04 | 18 | 34 | 2 | OBA_2045065 | |
| Disease | triglyceride measurement, alcohol drinking | 2.03e-04 | 99 | 34 | 3 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.16e-04 | 101 | 34 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 2.18e-04 | 19 | 34 | 2 | OBA_2045140 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.18e-04 | 19 | 34 | 2 | EFO_0802076 | |
| Disease | diacylglycerol 38:5 measurement | 2.18e-04 | 19 | 34 | 2 | EFO_0020067 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.22e-04 | 102 | 34 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.42e-04 | 20 | 34 | 2 | OBA_2045071 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 2.67e-04 | 21 | 34 | 2 | OBA_2045083 | |
| Disease | triacylglycerol 54:6 measurement | 2.93e-04 | 22 | 34 | 2 | EFO_0010424 | |
| Disease | phosphatidylserines measurement | 3.21e-04 | 23 | 34 | 2 | EFO_0020049 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 3.50e-04 | 24 | 34 | 2 | OBA_2045136 | |
| Disease | alpha-linolenic acid measurement | 3.80e-04 | 25 | 34 | 2 | EFO_0007759 | |
| Disease | non-Hodgkins lymphoma | 3.80e-04 | 25 | 34 | 2 | EFO_0005952 | |
| Disease | endometriosis (is_marker_for) | 3.80e-04 | 25 | 34 | 2 | DOID:289 (is_marker_for) | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 4.12e-04 | 26 | 34 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 4.12e-04 | 26 | 34 | 2 | OBA_2045087 | |
| Disease | esterified cholesterol measurement | 4.32e-04 | 128 | 34 | 3 | EFO_0008589 | |
| Disease | blood manganese measurement | 4.44e-04 | 27 | 34 | 2 | EFO_0007581 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 4.78e-04 | 28 | 34 | 2 | OBA_2045139 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.78e-04 | 28 | 34 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | cholesteryl ester 22:6 measurement | 6.25e-04 | 32 | 34 | 2 | EFO_0010350 | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 6.25e-04 | 32 | 34 | 2 | EFO_0007663, EFO_0007826 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 7.06e-04 | 34 | 34 | 2 | EFO_0010368 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 7.06e-04 | 34 | 34 | 2 | EFO_0004458, EFO_0004612 | |
| Disease | triacylglycerol 56:8 measurement | 7.92e-04 | 36 | 34 | 2 | EFO_0010435 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 8.58e-04 | 162 | 34 | 3 | EFO_0004612, EFO_0007878 | |
| Disease | lymphoid leukemia | 8.83e-04 | 38 | 34 | 2 | EFO_0004289 | |
| Disease | triacylglycerol 50:3 measurement | 9.30e-04 | 39 | 34 | 2 | EFO_0010410 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 9.53e-04 | 168 | 34 | 3 | EFO_0004329, EFO_0004612 | |
| Disease | cholesteryl ester 18:3 measurement | 9.78e-04 | 40 | 34 | 2 | EFO_0010346 | |
| Disease | Inherited neuropathies | 9.78e-04 | 40 | 34 | 2 | C0598589 | |
| Disease | lysophosphatidylethanolamine measurement | 1.03e-03 | 41 | 34 | 2 | EFO_0010225 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.08e-03 | 42 | 34 | 2 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.13e-03 | 43 | 34 | 2 | EFO_0022278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPAPLYELMKNCWAY | 851 | P21709 | |
| CMANGLWDRSLPKCL | 2841 | Q96PZ7 | |
| AKLQEPWSCYMCLPQ | 516 | Q9UBC3 | |
| LMFAWKIAPALCCGN | 191 | O94788 | |
| MLVWKLAPALCCGNT | 186 | P47895 | |
| VLWMAPDGLYAKRLC | 316 | Q15306 | |
| MGVCGYLFLPWKCLV | 1 | Q9P121 | |
| CLLTCPLIGYIMDWR | 366 | O75387 | |
| PTQGTKYMLNCNCWL | 1511 | Q8IVV2 | |
| LMALLGCWQPLCKSY | 21 | Q6UX53 | |
| WKYCEIPACQMPGNL | 106 | Q96MU8 | |
| LLASLNSCCNPWIYM | 316 | P30559 | |
| SWRLCAAILPLYCAM | 176 | Q5VZY2 | |
| PLFVWKMGRLLQYSC | 251 | Q6UXL0 | |
| QGLLKMQFWPASYLC | 291 | Q9BQG0 | |
| MGVCGYLFLPWKCLV | 1 | Q14982 | |
| KCAFLLFCMAPRPWN | 116 | Q96HR9 | |
| DWNPCKAAGVCLMLL | 341 | Q14974 | |
| WLMCMCRLNPGIYPQ | 556 | Q14D33 | |
| MPCVGSCQLLLNKFW | 186 | O14804 | |
| SHWKCLLLSLLMYGC | 61 | Q8IW70 | |
| LLANCVAPWALKYMN | 391 | Q8IVM8 | |
| NCPPTLYSLMTKCWA | 646 | Q05397 | |
| PAKWVTCLRDYCLMP | 71 | Q9BSH3 | |
| CRYGLSLAWYPCMLK | 216 | Q86UD1 | |
| LWCYLPAKGCLKLCQ | 266 | O43597 | |
| GPGCCQKRWMVYLCL | 161 | Q6ZS10 | |
| CPMCKLDVIKALGYW | 306 | Q8NC42 | |
| ALLLWCQMKTAGYPN | 181 | O15020 | |
| YNMWISLLGAILCCI | 711 | P55011 | |
| ISLRPDMYPCSLCWK | 211 | P49754 | |
| MQCWQLLALCAPLFL | 916 | Q9ULM0 | |
| GTVCMLYLLPLCWVL | 191 | Q5T4F4 | |
| GCPSKLYRLMQRCWA | 1031 | Q13308 | |
| CLGNRTFPKMLYCNW | 166 | Q9BRN9 | |
| LYNLMRLCWSKLPAD | 831 | O15146 |